2015 annual financial data

Tempest Therapeutics, Inc. 2015 Operating margin

Tempest Therapeutics, Inc. 2015 operating margin with verified reported values.

Direct answer

Operating margin was -25,992.42%.

Operating income was -71,999,000 USD and net income was -73,219,000 USD.
Operating cash flow was -50,286,000 USD.

Get free Tempest Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
277,000 USD
Operating income
-71,999,000 USD
Net income
-73,219,000 USD
Operating cash flow
-50,286,000 USD